Heart Disease Trial, Recruiting NCT04343430 Sponsor: Central Hospital, Nancy, France Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04343430
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to hospital with acute (sudden or severe) heart failure
  • People whose heart is pumping with a normal or near-normal squeezing strength (called "preserved ejection fraction," meaning the heart pumps out at least 50% of its blood with each beat)
  • People who are considered medically ready to be discharged from hospital after their heart failure episode
  • People aged 18 or older
  • People who have been fully informed about how the study works and have signed a consent form agreeing to take part
  • People who are covered by a French social security scheme

Who may not be able to join:

  • People with another serious illness where life expectancy is 3 months or less
  • People who are on dialysis (either peritoneal dialysis or haemodialysis), or whose kidneys are functioning at a very low level at the time of joining the trial (confirm with trial site)
  • People who have previously had surgery to remove part or all of a lung
  • People with serious lung or chest lining conditions that would make it difficult to get clear lung ultrasound images — for example, severe emphysema, long-term fluid around the lungs, or pulmonary fibrosis
  • People who are pregnant, in labour, or currently breastfeeding
  • People who are under a legal protection order, such as guardianship or a similar arrangement under French law
  • People who are not able to give their own informed consent
  • People who are currently held in detention or deprived of their liberty by a court or administrative decision
  • People currently receiving compulsory psychiatric care under specific French public health laws

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 33 3 83 15 73 22

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 August 2020
Est. completion
29 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of all-cause death; Rate of re-hospitalisation for acute heart failure; Rate of day-hospital or in-home IV diuretics injection for acute HF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov